It’s the only, early-stage risk assessment test

for veteran patients in stages 1-3b.

  • KidneyIntelX is the only bioprognostic methodology and the only option for early-stage risk assessment in veteran patients with type 2 diabetes and with chronic kidney disease stages 1-3b.
  • Demonstrated to be a 3X better predictor of risk vs traditional kidney function measures (eGFR and UACR)
Why Better?
See Evidence
Request a Meeting
Order Test

KidneyIntelX begins at the
right starting point.

Only by starting at the earliest stages of diagnosed diabetic kidney disease – and by leveraging the only test demonstrated to identify those select adult veteran patients with type 2 diabetes and chronic kidney disease who are at higher to lower risk for rapid progressive decline in kidney function – will clinicians and veterans reap the greatest benefits from the rest of the treatment plan.

Prognosis, not Diagnosis